Nitroxide Antioxidant Modulation of COX1 Gene Expression

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

There is a need to effectively decrease the expression levels of cyclooxygenase 1 (COX1) genes in human subjects, particularly those over 35 years old, to treat various diseases associated with overexpression of COX1.

Innovation Solution

Administering an effective amount of a nitroxide antioxidant, such as 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl, to human subjects identified with increased COX1 expression levels, thereby reducing the expression levels of the COX1 gene.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If COX1 gene expression is increased, then protective functions against oxidative stress are enhanced, but disease risk increases due to overexpression

Engineering Contradiction:

Improveprotective function against oxidative stressVSAvoiddisease risk from overexpression

Core Design Contradiction:

ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent uses nitroxide compounds to modulate COX1 gene expression levels, changing the expression parameter from overexpressed to physiologically appropriate levels. This resolves the contradiction by adjusting the expression parameter to achieve both protective function and disease prevention

Inventive Principle:

Principle #35Parameter changes

Solution Approach 2:

The patent employs antioxidants that respond to oxidative stress conditions to regulate COX1 expression. The system provides feedback control where oxidative stress triggers antioxidant activity which in turn modulates gene expression to maintain homeostasis, preventing both deficiency and overexpression

Inventive Principle:

Principle #23Feedback

2Stability of the object's composition

If natural control of gene expression is relied upon, then physiological homeostasis is maintained, but disease develops when control fails

Engineering Contradiction:

Improvephysiological homeostasisVSAvoiddisease prevention capability

Core Design Contradiction:

Stability of the object's compositionVSReliability

Solution Approach 1:

The patent introduces nitroxide antioxidants as intermediary substances that mediate between oxidative stress conditions and COX1 gene expression. These intermediaries enhance the reliability of gene expression control by providing an additional regulatory layer that supports natural control mechanisms

Inventive Principle:

Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent employs preventive administration of antioxidants to maintain appropriate COX1 expression levels before disease develops. This preliminary action ensures gene expression remains within physiological ranges, preventing disease onset rather than treating established conditions

Inventive Principle:

Principle #10Preliminary action

Data Source

PatentUS20250041285A1Modifying the expression level of a gene encoding an cyclooxygenase enzyme by treating a human subject with a nitroxide

Publication Date: 2025.02.06 HABASH LOUIS

AI summary

Some embodiments disclosed herein include a method for increasing an expression level of a gene. The methods can include identifying a human subject having an increased expression level of COX1; and administering to the human subject an effective amount of a nitroxide antioxidant, whereby expression level of the gene is decreased.